India becomes talent factory for P&G worldwide; Sundar Raman joins global ranks
Darpan News Desk IANS, 07 Oct, 2021 11:11 AM
Mumbai, Oct 7 (IANS) Procter & Gamble has announced the appointment of Sundar Raman as the global CEO of the company's fabric and home care division, which includes P&G's most iconic brands like Ariel, Tide, Ambipur and Downy.
He steps into the role subsequent to Shailesh Jejurikar's elevation to Chief Operating Officer.
Sundar began his career as a market analyst in India in 1998 straight from campus and soon moved to the US where he worked in a variety of roles from business intelligence to marketing, in P&G Beauty.
A visionary leader with broad expertise and a passion for innovation, Sundar was involved in the launch of new products such as Tide Pods and Downy Unstoppables. He also leads Equality Inclusion for Fabric Home Care reflecting his passion for diversity, inclusion and the company's Citizenship agenda.
He has earned his degree in electrical and electronics engineering from Indian Institute of Technology, Madras (1996) and a post-graduate diploma from Indian Institute of Management, Calcutta (1998).
India has been a talent factory for P&G worldwide and one of the largest exporters of top talent to P&G globally. The company has approximately 350 Indian expats in roles across the company with the recent being Shailesh Jejurikar becoming the first Indian to be elevated to COO of the company.
Maharastrian filmmaker Chaitanya Tamhane has had a year. His second feature, The Disciple, not only found its way to the Toronto and Venice Film Festivals, it won Best Screenplay at the latter and was acquired by Netflix.
Darpan Magazine had an opportunity to host him and listen to his incredible Light Journey at the 7th Annual Extraordinary Achievement Awards where he was the recipient of the International Sensation Award. Darpan is saddened to learn about his passing away and we offer our heartfelt condolences to his family.
Established in 2013, GloPID-R brings together research funding organizations on a global scale to facilitate effective and rapid research in response to a significant outbreak of an infectious disease with epidemic and pandemic potential.